Exponent stock reports stronger Q2 revenue and EPS

Published on 09/28/2026 at 19:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Exponent stock traded at USD 64.33 on September 28, 2026, while JPMorgan's target stands at USD 90.00. Q2 net revenue rose 12.00 percent year over year.

EXPO, US30214U1025, Illustration mit AI erstellt.

Exponent stock (ISIN US30214U1025) was trading at USD 64.33 on Nasdaq on September 28, 2026 at 1:34 p.m. ET, up 0.24 percent from the prior close. The latest results showed faster growth in total revenue than in the company's underlying net revenue, giving investors two different measures of Q2 performance.

Q2 revenue grows 21.00 percent

According to the Yahoo Finance transcript dated July 30, 2026, Exponent's Q2 2026 total revenue increased 21.00 percent year over year to USD 171.6 million. Net revenue, which excludes reimbursements, rose 12.00 percent to USD 148.9 million.

The same quarter produced net income of USD 29.4 million, up 11.00 percent from USD 26.6 million, while diluted EPS increased 15.00 percent to USD 0.60 from USD 0.52. A large user research study contributed to the quarter, representing 4.00 percent of net revenue versus the 2.00 percent expected for the project.

AI demand supports 2026 guidance

Exponent's management linked Q2 demand to user research for AI-enabled products, infrastructure work in the utility sector and reactive assignments in consumer products, chemicals and transportation. The transcript also said engineering and other scientific services represented 85.00 percent of Q2 net revenue, compared with 15.00 percent for environmental and health services.

For full-year 2026, management expects net revenue growth of 9.00 percent to 10.00 percent and EBITDA of 27.80 percent to 28.10 percent of net revenue, according to Yahoo Finance. The guidance makes utilization, staffing and the conversion of AI-related demand into recurring work key measures for the next report.

Analyst target remains above market price

As MarketBeat reported on September 22, 2026, JPMorgan raised its Exponent price target from USD 80.00 to USD 90.00 and kept an overweight rating in a report dated July 31, 2026. The target lies 39.90 percent above the September 28, 2026 market price, while MarketBeat cited a Moderate Buy consensus and an average target of USD 81.00.

EXPO trades below its yearly high

Exponent stock was trading at USD 64.33 on Nasdaq on September 28, 2026, with a market capitalization of USD 3.1 billion and volume of 173,679 shares. The price stood 21.50 percent below the 52-week high of USD 81.95 and above the 52-week low of USD 51.91, keeping the analyst target and the company's 2026 execution as the central valuation reference points.